BioStrand

08/06/2023

Meet Michael Best!

With a background in engineering and expertise in data analysis, Michael brings a fresh perspective to the biotech industry.

He holds a Master's Degree in Bioinformatics and Systems Biology, and has made significant contributions to developing data-driven solutions in his previous role.

We're thrilled to have him on board as we leverage his skills to drive innovation at BioStrand!

Read his interview here. Employee Spotlight with Michael Best https://bit.ly/3Ckp4KA

Michael joined the BioStrand Team in March 2023 as a Data Engineer.

10/05/2023

Embracing effective is a cultural shift that can transform the way we conduct research.

By leveraging established methodologies and frameworks, we can streamline processes, avoid reinventing the wheel, and accelerate our journey towards improved data management.

We are delighted to introduce our new data management blog series, where we will explore the crucial role of effective data management in optimizing research outcomes.

Our first blog delves into various frameworks that offer valuable guidance in this domain. From the principles to the DMBOK, TOGAF, ITIL, and COBIT, these frameworks provide researchers with the necessary tools and best practices to improve data management strategies and navigate the complexities of data-sharing policies.

Read our blog now. https://hubs.li/Q01Pj2lH0

Data management & sharing are increasingly becoming mandated for life sciences R&D, both by upstream funding agencies and downstream scientific journals.

03/05/2023

Meet Julie Delanote!

Armed with master's degrees in business and information systems engineering and and systems biology, Julie can connect the dots between data analysis, biology, and business management, making her an invaluable asset to our team at BioStrand.

Beyond her academic achievements, Julie has a keen interest in , nutritional and science, and preventive medicine.

We're delighted to have her on board!

Read her interview here. Employee Spotlight with Julie Delanote https://hubs.li/Q01NtcrY0

Julie joined the BioStrand Technology Team shortly before the end of 2022 as a Data Scientist.

25/04/2023

Happy !

Today we celebrate the anniversary of two significant milestones in the revolution - the discovery of the double helix structure of DNA in 1953 and the completion of the Human Genome Project in 2003.

On this special day, we reflect on the incredible impact of genomics on biomedical research and medicine. Genomics has revolutionized healthcare, from to gene therapy, transforming the way we approach the diagnosis, treatment, and prevention of diseases.

At BioStrand, we are proud to be at the forefront of this revolution, harnessing the power of DNA to revolutionize drug discovery. We believe in a healthier future for all, made possible by the amazing possibilities of genomics.

Let's celebrate this DNA Day by recognizing the incredible achievements made possible by genomics, and by continuing to work towards a brighter and healthier future.
https://hubs.li/Q01MDdBz0

On DNA Day, here’s a quick look at the continuing impact of the genomics revolution on biomedical research and medicine.

19/04/2023

The crisis, in academic research and ML-based sciences, has serious implications for in-silico .

Here’s an overview of some of the key issues and the way forward.

Read our new blog. https://hubs.li/Q01M0PhP0

The reproducibility crisis, in academic research and ML-based sciences, has serious implications for in silico drug discovery. Here’s an overview of some of the key issues and the way forward.

17/04/2023

Are you ready to be part of a revolutionary movement in the field of biotherapeutics?

At BioStrand, we are driven to develop cutting-edge technology and we are seeking innovative thinkers to join us in shaping the future of in silico .

If you are passionate about pushing the boundaries of scientific research, explore our open positions and apply now!

https://hubs.li/Q01LD4Tn0

06/04/2023

The presence of multiple data silos, the proliferation of proprietary data, and the abundance of redundant/replicated data are some of the biggest challenges in drug discovery.

Learn why a cloud based system has an edge over an on-premise architecture in terms of flexibility, collaboration, and scale.

Read the blog here. https://hubs.ly/Q01KvgWJ0

30/03/2023

🔬 With 175 therapeutics in regulatory review or approved, and 1200 in clinical studies, it is evident that the use of antibodies and monoclonal antibodies (mAbs) in is becoming increasingly important.

💡 As the industry continues to evolve, the demand for innovative antibody development approaches is rapidly increasing.

In the first article of our three-part series on antibodies and mAbs in drug development, we dive into the fundamentals and key terminologies that are shaping the future of the industry.

🔍 Read our blog here. Targeting Disease with Precision: A Primer on Antibody Discovery https://hubs.li/Q01JDyKs0

In this article, we discuss some of the fundamental concepts and terminologies associated with the future of the pharmaceutical industry.

22/03/2023

🤔 prediction is essential for understanding protein function, yet it is experimentally costly and time-consuming.

💻 Recent advances in , particularly , can accelerate functional annotation of proteins starting from their structure, including predicting molecular function and paratope/epitope binding for .

🔍👨‍💻 In this second blog of the protein structure prediction series, our Tom Vieijra explores how combining structure prediction with physics-based approaches and state-of-the-art machine learning techniques can close the gap to functional prediction.

Read the blog here.

In this blog, Tom Vieijra explores how combining structure prediction with physics-based approaches can close the gap to functional prediction.